(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 6.16% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.87%.
Tandem Diabetes Care's revenue in 2025 is $1,001,719,000.On average, 6 Wall Street analysts forecast TNDM's revenue for 2025 to be $67,496,901,388, with the lowest TNDM revenue forecast at $67,280,949,359, and the highest TNDM revenue forecast at $67,764,476,493. On average, 7 Wall Street analysts forecast TNDM's revenue for 2026 to be $74,179,792,348, with the lowest TNDM revenue forecast at $71,974,324,814, and the highest TNDM revenue forecast at $77,502,183,237.
In 2027, TNDM is forecast to generate $81,024,106,774 in revenue, with the lowest revenue forecast at $77,271,028,077 and the highest revenue forecast at $86,151,075,525.